IDiyas

For the Inventor, By the Inventor

Funabashi, Japan

Yoshihiro Fujikawa

USPTO Granted Patents = 18

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 188(Granted Patents)


Location History:

  • Tokyo, JP (1984)
  • Sakura, JP (1988)
  • Chiba, JP (1989)
  • Funabashi, JP (1986 - 1999)

Company Filing History:

goldMedal18 out of 1,235 
 
Nissan Chemical Industries Limited
 patents

Years Active: 1984-1999

Loading Chart...
18 patents (USPTO):Explore Patents
1. 5872130 - Quinoline type mevalonoactones (1999-02-16),
2. 5856336 - Quinoline type mevalonolactones (1999-01-05),
3. 5854259 - Quinoline type mevalonolactones (1998-12-29),
4. 5137891 - 2',3' cyclic fused pyrazolopyrimidine type mevalonolactones (1992-08-11),
5. 5102888 - Quinoline type mevalonolactones useful for treating hyperlipidemia and (1992-04-07),
6. 5055472 - Pyrazolopyrimidine type mevalonolactones (1991-10-08),
7. 5026708 - Pyrimidine type mevalonolactones (1991-06-25),
8. 5026698 - Thienopyridine type mevalonolactones (1991-06-25),
9. 5024999 - Pyrazolopyridine type mevalonolactones useful as pharmaeuticals (1991-06-18),
10. 5011930 - Quinoline type mevalonolactones (1991-04-30),
11. 4977161 - Isoxazolopyridine type mevalonolactones (1990-12-11),
12. 4841068 - 3-hydroxy pyrazole derivatives (1989-06-20),
13. 4746663 - Pyrazolo[4,3-d]pyrimidine derivative, process for its production, and (1988-05-24),
14. 4719209 - Antiatherosclerotic agent compositions (1988-01-12),
15. 4654348 - Pyrazolo[4,3-d]pyrimidine derivative, process for its production, (1987-03-31),

Title: The Innovative Contributions of Yoshihiro Fujikawa

Introduction

Yoshihiro Fujikawa is a prominent inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cholesterol biosynthesis. With a total of 18 patents to his name, Fujikawa's work has had a notable impact on medical science.

Latest Patents

Fujikawa's latest patents include innovative quinoline type mevalonolactones. These patents describe mevalonolactone derivatives that feature a quinoline ring structure. One of the compounds detailed in his patents has the formula Z=--CH(OH)--CH.sub.2 --CH(OH)--CH.sub.2 --COO.1/2Ca, which exhibits HMG-CoA inhibiting effects. This makes these compounds useful as pharmaceutical agents for reducing conditions such as hyperlipidemia, hyperlipoproteinemia, and atherosclerosis.

Career Highlights

Fujikawa is currently associated with Nissan Chemical Industries Limited, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding of cholesterol biosynthesis and its implications for health.

Collaborations

Fujikawa has collaborated with notable colleagues, including Mitsuaki Sakashita and Mikio Suzuki. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.

Conclusion

Yoshihiro Fujikawa's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments aimed at combating cholesterol-related health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…